← vista completa

Publicado el 1 de noviembre de 2008 | http://doi.org/10.5867/medwave.2008.10.1784

Nuevas formas de terapia antibiótica en unidad de cuidados intensivos

New forms of antibiotic therapy in intensive care unit

Mario Luppi N.

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Mario Luppi N.

Unidad de Infectología Hospital Clínico Universidad de Chile
Unidad de Infectología Fundación Arturo López Pérez, Santiago, Chile

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Luppi N. M. New forms of antibiotic therapy in intensive care unit. Medwave 2008;8(10):e1784 doi: 10.5867/medwave.2008.10.1784

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 01/11/2008

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Referencias

  1. Brinquin L, Rousseau JM, Boulesteix G, Diraison Y, Bonsignour JP. Continuous infusion of vancomycin in post-neurosurgical staphilococcal meningitis in adults. Presse Med. 1993 Nov 20;22(36):1815-7. | PubMed
  2. Conil JM, Favarel H, Laguerre J, Brouchet A, Chabanon G, Cazal L, et al. Continuous administration of vancomycin in patientes with severe burns. Presse Med. 1994 Nov 5;23(34):1554-8. | PubMed
  3. Borderon JC, Laugier J, Chamboux C, Saliba E, Mathieu A. Continuous infusion of vancomycin durong the neonatal period. Pathol Biol (Paris) 1994 May; 42(5):525-9. | PubMed
  4. Jourdan C, Convert J, Peloux A, Boussaid O, Grando J, Tigaud S. Adequate intrathecal diffusion of teicoplanin after failure of vancomycin in continuous infusion in threecases of shunt associated meningitis. Pathol Biol (Paris) 1996 May;44(5):389-92. | PubMed
  5. James JK, Palmer SM, Levine DP, Rybak MJ. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother. 1996 Mar;40(3):696-700. | PubMed
  6. Di Filippo A, De Gaudio AR, Novelli A, Paternostro E, Pelagatti C, Livi P, et al. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection. Chemotherapy. 1998 Jan-Feb;44(1):63-8. | CrossRef | PubMed
  7. Klepser ME, Patel KB, Nicolau DP, Quintiliani R, Nightingale CH. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy. 1998 Sep-Oct 18 (5):1069-74. | PubMed
  8. Lacy MK, Tessier PR, Nicolau DP, Nightingale CH, Quintiliani R. Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci. Int J Antimicrob Agents. 2000 Jun;15(1):25-30. | CrossRef | PubMed
  9. Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother. 2001 Sep;45(9):2460-7. | CrossRef | PubMed
  10. Cohen E, Dadashev A, Drucker M, Samra Z, Rubinstein E, Garty M. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. J Antimicrob Chemother. 2002 Jan;49 (1):155-60. | CrossRef | PubMed
  11. Byl B, Jacobs F, Wallemacq P, Rossi C, de Francquen P, Cappello M, et al. Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion. Antimicrob Agents Chemother. 2003 Jun;47(6):2015-7. | CrossRef | PubMed
  12. Frei CR, Burgess DS. Continuous infusion beta-lactams for intensive care unit pulmonary infections. Clin Microbiol Infect. 2005 May;11(5):418-21. | CrossRef | PubMed
  13. Lorente L, Lorenzo L, Martín MM, Jiménez A, Mora ML. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother. 2006 Feb;40(2):219-23. Epub 2006 Jan 31. | CrossRef | PubMed